Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immune Therapeutics Inc (OTCQB:IMUN)

0.167
Delayed Data
As of Jul 25
 -0.003 / -1.76%
Today’s Change
0.08
Today|||52-Week Range
0.36
-24.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.0016.2K
 
 
Depreciation And Amortization1.6M2.9M2.9M594.8K
 
 
 
 
 
 
Operating ExpensesGross Income-1.6M-2.9M-2.9M--
 
 
 
 
General Expenses27.7M93.1M30.7M10.0M
 
 
 
 
 
Other Operating Expenses0.000.000.0046.2K
 
 
Research And Development5.0M22.0M7.5M977.2K
 
 
 
 
 
Total Operating Expenses29.3M96.0M33.6M10.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-29.3M-96.0M-33.6M-10.6M
 
 
 
 
 
Extraordinary Charge-145.9M-8.6M-15.9M-6.1M
 
 
 
 
 
Interest Expense On Debt27.0K1.4M388.2K271.0K
 
 
 
 
 
Other Expenses0.00-224.00-783.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-175.2M-106.1M-49.9M-16.9M
 
 
 
 
 
Minority Interest0.000.00-1.7M-635.7K
 
 
 
Discontinued Operations231.4K0.000.000.00
 
 
Net Income-175.0M-106.1M-48.3M-16.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.6M57.2M98.5M153.2M
 
 
 
 
 
Shares To Calculate EPS Diluted25.6M57.2M98.5M153.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.84-$1.85-$0.49-$0.11
 
 
 
 
 
EPS Diluted-$6.84-$1.85-$0.49-$0.11